Big Pharma
A protective Alzheimer’s disease genetic variant has beneficial effects on amyloid-beta metabolism
A protective Alzheimer’s disease genetic variant has beneficial effects on amyloid-beta metabolism A new study conducted by researchers at the University of Eastern Finland discovered that the APP A673T genetic variant, which protects against Alzheimer’s disease, alters levels of several proteins and peptides linked to amyloid-beta metabolism in human biofluids and cell culture models, including amyloid beta itself. These new data support the idea that even a modest reduction in the beta-amyloidogenic processing of APP may be a feasible strategy for the prevention of Alzheimer's disease. Alzheimer’s disease (AD) is the most common form of dementia with more than 40...
VIRGIN ATLANTIC PARTNERS WITH CARDIOSECUR TO FURTHER ENHANCE IN-FLIGHT MEDICAL SAFETY
VIRGIN ATLANTIC PARTNERS WITH CARDIOSECUR TO FURTHER ENHANCE IN-FLIGHT MEDICAL SAFETY Airline continues its commitment to customer safety and innovation through latest investment with CardioSecur Virgin Atlantic remains the UK’s only airline to have 12 lead ECG capability in-flight It was the first airline in the world to have a fully ECG equipped fleet Virgin Atlantic is upgrading its on-board safety equipment and bolstering its dedication to passenger health, thanks to a new partnership with CardioSecur, a pioneering medical tech provider from Germany. From today, all flights will be equipped with the world’s smallest and lightest...
OMRON Healthcare President and CEO Ranndy Kellogg Named one of Crain's Notable Leaders in Health Care 2023
OMRON Healthcare President and CEO Ranndy Kellogg Named one of Crain's Notable Leaders in Health Care 2023 Crain's Chicago Business recognizes Mr. Kellogg as a health care leader making a significant industry impact and driving meaningful change HOFFMAN ESTATES, Ill., May 2, 2023 /PRNewswire/ -- OMRON Healthcare, Inc., the global leader in personal heart health and wellness technology, today announced that President and CEO Ranndy Kellogg is recognized in the inaugural Most Notable Leaders in Health Care 2023 list issued by Crain's Chicago Business. OMRON Healthcare, Inc. announced that President and CEO Ranndy Kellogg is recognized in the inaugural Most Notable...
FDA Approves First Over-the-Counter Naloxone Nasal Spray
FDA Approves First Over-the-Counter Naloxone Nasal Spray Agency Continues to Take Critical Steps to Reduce Drug Overdose Deaths Being Driven Primarily by Illicit Opioids SILVER SPRING, Md., March 29, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. Today's action paves the way for the life-saving medication to reverse an opioid overdose to be...
SNOO is Granted FDA De Novo Approval For Keeping Sleeping Babies Safely Positioned on the Back
SNOO is Granted FDA De Novo Approval For Keeping Sleeping Babies Safely Positioned on the Back WASHINGTON, April 3, 2023 /PRNewswire/ -- Marking a significant advance in infant safety, the U.S. Food and Drug Administration (FDA) has given De Novo approval to Happiest Baby's SNOO Smart Sleeper. This is the first time the FDA has given De Novo approval to a product designed to keep sleeping babies safely positioned on the back. Babies who are positioned to sleep on the back are at a lower risk of SIDS. SNOO is Granted FDA De Novo Approval For Keeping Sleeping Babies Safely Positioned...